D-dimer and clinicoradiologic features in cerebral venous thrombosis

J Neurol Sci. 2013 Apr 15;327(1-2):12-4. doi: 10.1016/j.jns.2013.01.033. Epub 2013 Feb 20.

Abstract

Objectives: Cerebral venous thrombosis (CVT) is a disease with varying clinical presentation and diagnosis presents many challenges in clinical practice. We investigated, whether D-dimer levels reflect clinical presentation, radiologic features, and outcome in CVT.

Methods: We included all consecutive patients with CVT treated in our hospital from 1987 to 2010 with D-dimer levels measured before initiation of anticoagulant treatment. D-dimer was categorized as low (<0.5mg/L), intermediate (0.6-2.0mg/L), and high (>2.0mg/L). Based on delay from symptom onset to hospital presentation mode of onset was categorized as acute (<2 days), subacute (2-14 days), or chronic (>14 days).

Results: In 71 patients included median level of D-dimer was 1.40 mg/L (range 0.05-13.0mg/L). In 9 (12%) patients D-dimer was low, and of these, 7 presented with subacute and 2 with chronic mode of symptom duration. Elevated D-dimer levels were associated with thrombosis in multiple sinuses (P=0.044). Longer symptom duration was correlated with low D-dimer levels (P=0.010).

Conclusions: In clinical practice, low levels of D-dimer cannot rule out CVT in patients with subacute or chronic disease. High D-dimer levels correlate with greater thrombus extension and acute onset of symptoms.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Biomarkers / blood
  • Female
  • Fibrin Fibrinogen Degradation Products / metabolism*
  • Humans
  • Intracranial Thrombosis / blood*
  • Intracranial Thrombosis / diagnosis*
  • Male
  • Middle Aged
  • Retrospective Studies
  • Venous Thrombosis / blood*
  • Venous Thrombosis / diagnosis*
  • Young Adult

Substances

  • Biomarkers
  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D